Three rapid tests for hepatitis B surface antigen (HBsAg) detection (VIKIA?, Determine? and Quick Profile?) and one test for anti-hepatitis B surface antibody (anti-HBsAb) detection (Quick Profile?) were evaluated in comparison to ELISA serology. Sensitivity (Se), specificity (Sp), positive and negative predictive values (PPV and NPV, respectively) and area under the ROC curve were used to estimate test performance. Non-inferiority criteria of the joint Se, Sp were set at 0.80, 0.95.
Among the 3956 subjects screened, 85 (2.1 % ) were HBsAg-positive and 2225 (56.5 % ) had a protective anti-HBsAb titer. Test Se and Sp (lower bound of 97.5 % CI) were as follows: 96.5 % (89.0 % ), 99.9 % (99.8 % ) for Vikia?; 93.6 % (80.7 % ), 100.0 % (99.8 % ) for Determine?; and 90.5 % (80.8 % ), 99.7 % (99.5 % ) for Quick Profile?; with all three tests achieving minimal non-inferiority criteria. False negatives were typically observed in inactive HBsAg carriers. The anti-HBsAb Quick Profile? test had excellent specificity (97.8 % ) and PPV (97.8 % ) albeit low sensitivity (58.3 % ), thus failing to establish non-inferiority.
All three HBsAg rapid tests could be considered ideal for HBV screening in low HBV-prevalent countries, given the ease of use, rapidity, and high classification probabilities. The anti-HBsAb Quick Profile? could be considered reliable only for positive tests.